These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6152269)

  • 1. Evaluation of the effects of SKF 82526 and LY 171555 on presynaptic (DA2) and postsynaptic (DA1) dopamine receptors in rat kidney.
    Lokhandwala MF; Steenberg ML
    J Auton Pharmacol; 1984 Dec; 4(4):273-7. PubMed ID: 6152269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Jan; 236(1):65-70. PubMed ID: 2867216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine.
    Lokhandwala MF; Steenberg ML
    J Pharmacol Exp Ther; 1984 Jan; 228(1):161-7. PubMed ID: 6694099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats.
    Sengupta S; Lokhandwala MF
    J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
    Dupont AG; Lefebvre RA; Vanderniepen P
    Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic dopamine DA2-receptors in rabbit jejunal arteries. An electrophysiological study.
    Nörenberg W; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):151-60. PubMed ID: 2572971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular effects of selective dopamine receptor agonists and antagonists in the rat kidney.
    Schmidt M; Krieger JP; Giesen-Crouse EM; Imbs JL
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):195-205. PubMed ID: 2954515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices.
    Rump LC; Schwertfeger E; Schuster MJ; Schaible U; Frankenschmidt A; Schollmeyer PJ
    Kidney Int; 1993 Jan; 43(1):197-204. PubMed ID: 8094472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dopamine2-receptors in mediating renal vascular response to low dose dopamine infusion in the rat.
    Seri I; Eklöf AC; Aperia A
    Acta Physiol Scand; 1987 Aug; 130(4):563-9. PubMed ID: 3630734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T; Sharp T; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors.
    Lokhandwala MF; Watkins HO; Sabouni MH; Alkadhi KA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):337-44. PubMed ID: 2862275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature.
    Horn PT; Kohli JD
    Eur J Pharmacol; 1991 May; 197(2-3):125-30. PubMed ID: 1680707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390.
    Serra G; Collu M; Gessa GL
    Psychopharmacology (Berl); 1987; 91(3):330-3. PubMed ID: 2882540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postsynaptic dopamine DA1- and DA2-receptors in jejunal arteries of rabbits.
    Münch G; Raether A; Schöffel E; Illes P
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):468-71. PubMed ID: 1720848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats.
    Cavero I; Thiry C; Pratz J; Lawson K
    Clin Exp Hypertens A; 1987; 9(5-6):931-52. PubMed ID: 2887315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both DA1 and DA2 receptor agonists are necessary to inhibit NaKATPase activity in proximal tubules from rat kidney.
    Bertorello A; Aperia A
    Acta Physiol Scand; 1988 Mar; 132(3):441-3. PubMed ID: 2906504
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrarenal DA2 dopamine receptor stimulation in the conscious dog.
    Siragy HM; Felder RA; Peach MJ; Carey RM
    Am J Physiol; 1992 Jun; 262(6 Pt 2):F932-8. PubMed ID: 1352430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
    Grega GJ; Barrett RJ; Adamski SW; Lokhandwala MF
    J Pharmacol Exp Ther; 1984 Jun; 229(3):756-62. PubMed ID: 6144791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.